SCHEMBL7389698

SCHEMBL7389698

BrCCCCOCc1ccc2c(c1)OCCO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 2/20 0.43
▸ UGCG Q16739 2/20 0.43
▸ GBA2 Q9HCG7 2/20 0.43
▸ MAOB P27338 7/20 0.42
▸ MAOA P21397 6/20 0.42
▸ CYP3A4 P08684 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ CYP2D6 P10635 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8556046 0.98 GBA1 (0.45) GBA1UGCGGBA2MAOBMAOA
SCHEMBL7393834 0.91 CYP3A4 (0.50) GBA1UGCGGBA2CYP3A4HSD17B10
SCHEMBL11777492 0.90 CYP3A4 (0.49) GBA1UGCGGBA2CYP3A4ALDH1A1
SCHEMBL11774893 0.90 CYP3A4 (0.49) GBA1UGCGGBA2CYP3A4ALDH1A1
SCHEMBL11773030 0.90 CYP3A4 (0.49) GBA1UGCGGBA2CYP3A4ALDH1A1
SCHEMBL11772170 0.90 CYP3A4 (0.49) GBA1UGCGGBA2CYP3A4ALDH1A1
SCHEMBL11775440 0.90 CYP3A4 (0.49) GBA1UGCGGBA2CYP3A4ALDH1A1
SCHEMBL11774715 0.90 CYP3A4 (0.49) GBA1UGCGGBA2CYP3A4ALDH1A1
SCHEMBL11776870 0.90 CYP3A4 (0.49) GBA1UGCGGBA2CYP3A4ALDH1A1
SCHEMBL11774160 0.90 CYP3A4 (0.49) GBA1UGCGGBA2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5864039-A THERAPEUTIC TREATMENT OF VARIOUS GASTROINTESTINAL DISEASES, CENTRAL NERVOUS DISORDERS, CARDIOVASCULAR DISORDERS, URINARY DISEASES, UROGENITAL DISORDERS YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-01-26 — — US disclosed
Send feedback